Email bookmark
Font : A-A+

Drug information on BIO-12 Forte TAB (Folic Acid) from Nostrum Pharmaceuticals

BIO-12 Forte TAB

  Tablet  
Nostrum Pharmaceuticals
Generic : Folic Acid
 139.00
1.5mg / 2500IU / 12.5IU / 5mg / 5mg / 3mg / 50mg / 1.5mg / 200mcg
10
Medindia currently has information on 3080 generic drugs and 110,061 brands that have their prices listed. New drugs with their prices are listed as and when they get approved by the drug controller. Please do write to us (info@medindia.net) if a drug is missing from our comprehensive drug price list.

Side effects of BIO-12 Forte TAB

Skin rash, itching, redness and difficulty in breathing.

Dosage & When it is to be taken (Indications)

Dose is based on patient's condition.

How to use BIO-12 Forte TAB?

It comes as a tablet to take by mouth, with or without food.

When is BIO-12 Forte TAB not to be taken? (Contraindications)

Hypersensitivity.

Warnings and Precautions for BIO-12 Forte TAB

Caution should be exercised in patients with history of long-term infection, seizure disorder, liver problems and kidney dialysis.

Other Precautions for BIO-12 Forte TAB

Avoid excess dosage.

Storage Conditions for BIO-12 Forte TAB

Store it at room temperature and away from direct sunlight (15-30°C).



Disclaimer :
Medindia.net updates the prices regularly, however despite that there may be discrepancies in the prices displayed. This can be due to many reasons including -
  • Difference in GST/local taxes
  • Change in price by the company
  • Updation of information may not have happened at the right time
For the above reasons Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to only provide the initial guidance and it does not intend to replace professional medical opinion in any manner whatsoever.

Buy Medicines (Drug) at Concessional Price from India
Substitutes for BIO-12 Forte TAB

View all

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.